Oxybenzone is the key component in majority of sunscreens. But the similar method that makes it separate UV light and stops sunburns in individuals makes it deadly to baby coral. Essentially, the ingredient in sunscreen is pushing coral reefs off the ridge on which they are already hovering.
Now Hawaii, which greets almost 9 Million sunscreen-using people each year, might turn into the first state in the U.S. to prohibit the ingredient. The state parliament approved a bill to prohibit the unlawful sale of over 3,500 oxybenzone goods this week in the market (along with goods that have octinoxate, a different ordinary ingredient in sunscreen). The bill has been in progress for more than 1 Year, and now awaits an approval from the governor of the state. Visitors and Hawaii residents will only be capable of buying sunscreen having the concerned ingredients with a doctor’s prescription.
Companies in the sunscreen industry are not happy. “The bill will prohibit “almost 70% of the products in the market, on the basis of weak science accusing sunscreens for spoiling the coral reefs,” claimed the Consumer Healthcare Products Association (CHPA) to the media in an interview. The CHPA involves members such as Johnson & Johnson. Bayer, which produces Coppertone’s sunscreens, claimed that the bill was in conflict with efforts taken for skin cancer prevention.
There are a number of FDA-accepted and mineral-based sunscreens accessible in the market that have either zinc oxide or titanium dioxide. In addition, there are a number of chemical sunscreens that do not have either octinoxate or oxybenzone.
In contrast, last week a media report revealed opposite thoughts. It claimed that banning the sunscreens will have negative effects on people lead to cancer. The report took help of a study that shows non-melanoma skin cancer impacts 3.5 Million people in the U.S. each year.
Sasha Farrell is a privileged and versatile content writer and editor in the domains of Pharma, Health, and Medical. Before getting into the writing world, Sasha was working as an STM editor for few renowned authors and publications, which gave head-start to rifle through the Pharma, Health, and Medical Innovations.